Transcriptomics

Dataset Information

0

Divergent resistance mechanisms to HER2-targeted therapies in breast cancer

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE161423 | GEO | 2021/04/21

REPOSITORIES: GEO

Json Xml

Similar Datasets

Transcriptomics Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (scRNA-Seq)
2021-04-21 | GSE161422 | GEO
Genomics Divergent resistance mechanisms to HER2-targeted therapies in breast cancer
| PRJNA678280 | ENA
Transcriptomics Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (bulkRNA-Seq and Exome-Seq)
2021-04-21 | GSE161420 | GEO
Genomics Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (scRNA-Seq)
| PRJNA678283 | ENA
Unknown Overcoming resistance and restoring sensitivity to HER2-targeted therapies in breast cancer.
| S-EPMC3501233 | biostudies-literature
Genomics Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies
2024-04-24 | GSE249574 | GEO
Unknown Targeted therapies for ER+/HER2- metastatic breast cancer.
| S-EPMC4462184 | biostudies-literature
Genomics Divergent resistance mechanisms to HER2-targeted therapies in breast cancer (bulkRNA-Seq and Exome-Seq)
| PRJNA678282 | ENA
Unknown CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies.
| S-EPMC6938262 | biostudies-literature
Unknown Targeted Therapies in HER2-Positive Breast Cancer - a Systematic Review.
| S-EPMC4569208 | biostudies-literature